National Institutes of Health: all 11,571 studies

Page 76 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• L-Carnitine to Treat Fatigue in AIDS PatientsCompletedNCT00079599Phase 2
• Comparison of Popular Weight Loss DietsCompletedNCT00079573Phase 2
• Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDSCompletedNCT00079560Phase 1/2
• Distant Healing for HIV/AIDSCompletedNCT00079534Not applicable
• Therapeutic Touch for Wrist Fractures in Postmenopausal WomenCompletedNCT00079521Phase 2
• Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to SmokeCompletedNCT00079469Not applicable
• Temsirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00079456Phase 2
• FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaTerminatedNCT00079443Phase 2
• Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00079430Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaCompletedNCT00079404Phase 1
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00079378Phase 1
• Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00079352Phase 1
• Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous LeukemiaCompletedNCT00079313Phase 2
• CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNCT00079235Phase 2
• Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00079170Not applicable
• Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00079144Phase 2
• Oblimersen in Treating Patients With Merkel Cell CarcinomaCompletedNCT00079131Phase 2
• 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid TumorsCompletedNCT00079014Phase 1
• GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
• Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerCompletedNCT00078910Phase 2
• Daclizumab and Sirolimus to Treat UveitisCompletedNCT00078689Phase 1
• Oral Care to Reduce Mouth and Throat Infections in Critically Ill PatientsCompletedNCT00078663Phase 3
• Peptide Vaccine to Prevent Recurrence of Nasopharyngeal CancerCompletedNCT00078494Phase 1
• Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaCompletedNCT00078481Phase 1
• Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected PeopleCompletedNCT00078442Phase 2
• Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHSCompletedNCT00078429
• Pain Pathways in the BrainCompletedNCT00078364Phase 2
• Synvisc to Treat Osteoarthritis of the Temporomandibular JointCompletedNCT00078351Phase 2
• Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading SystemCompletedNCT00078299
• Anti-HIV Drugs for Ugandan Patients With HIV and TuberculosisCompletedNCT00078247Phase 3
• Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With AsthmaCompletedNCT00078208
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal AllergiesCompletedNCT00078195Phase 2
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
• Prostanoid Levels After Medication to Prevent Pain Following Third Molar (Wisdom Tooth) ExtractionCompletedNCT00078104Phase 2
• Genetics and Clinical Characteristics of Bardet-Biedl SyndromeTerminatedNCT00078091
• Direct Current Brain Polarization in Frontotemporal DementiaCompletedNCT00077896Phase 1
• 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNCT00077545Phase 2
• Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV MelanomaCompletedNCT00077532Phase 2
• Bortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaCompletedNCT00077467Phase 1
• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077441Phase 2
• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and NeckCompletedNCT00077428Phase 2
• Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast CancerCompletedNCT00077363Phase 2
• A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
• Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal CancerCompletedNCT00077298Phase 2
• FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00077194Phase 2
• 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic MalignanciesCompletedNCT00077181Phase 1
• Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00077155Phase 1
• Brain Activity in Visual-Motor BehaviorCompletedNCT00077038
• Safety of the EnvPro HIV Vaccine in Healthy VolunteersCompletedNCT00076947Phase 1
• Safety of RG2077 in Patients With Multiple SclerosisCompletedNCT00076934Phase 1
• Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisCompletedNCT00076843Phase 1
• Evaluation and Treatment of Patients With Connective Tissue DiseaseCompletedNCT00076830
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the ArmCompletedNCT00076817Phase 1
• Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
• Study of Brain Function During Cognitive TasksCompletedNCT00076739
• Enhanced Tactile Memory in the BlindCompletedNCT00076700
• Levetiracetam Treatment of L-dopa Induced DyskinesiasCompletedNCT00076674Phase 2
• Brain Control of Movements in Cerebral PalsyCompletedNCT00076596
• Spinal Reflexes in Motor Skill LearningCompletedNCT00076583
• The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
• Cell Studies of Parkinson's DiseaseCompletedNCT00076505
• Role of the Right Brain in Recovery of Language Function in Chronic StrokeCompletedNCT00076479
• Brain Changes Associated With Learning a Motor TaskCompletedNCT00076466
• Leukapheresis for Research on HCV-Coinfected PatientsCompletedNCT00076427
• The Effect of Lopinavir/Ritonavir on Endothelial FunctionCompletedNCT00076414Phase 1
• GW873140 to Treat HIV-1 Infected AdultsCompletedNCT00076284Phase 2
• Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye DiseasesCompletedNCT00076271
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic LeukemiaCompletedNCT00076180Phase 1
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV VaccinesCompletedNCT00076063Phase 1/2
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEPCompletedNCT00076037Phase 1
• Technical Development of Strain Rate EchocardiographyCompletedNCT00075920
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected AdolescentsCompletedNCT00075907Phase 3
• Alanosine in Treating Patients With Progressive or Recurrent Malignant GliomasCompletedNCT00075894Phase 1
• Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00075751Phase 2
• CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00075647Phase 2
• Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaCompletedNCT00075634Phase 1
• Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma MultiformeTerminatedNCT00075491Phase 2
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
• Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau SyndromeCompletedNCT00075348
• FMRI Study of Performance During a Probabilistic Reversal Learning Task in DepressionCompletedNCT00075296
• Alternative Dosing and Regimen of Replagal to Treat Fabry DiseaseCompletedNCT00075244Phase 2
• Rimonabant to Reduce Alcohol ConsumptionCompletedNCT00075205Phase 2
• Surgery Versus Radiosurgery to Treat Metastatic Brain TumorsCompletedNCT00075166Phase 4
• Family Health After Predictive Huntington Disease (HD) TestingCompletedNCT00075140
• Sleep, Fatigue, and Dexamethosone in Children With LeukemiaCompletedNCT00075101Phase 3
• Infliximab to Treat Non-Infectious ScleritisCompletedNCT00075075Phase 1
• A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide TrialsCompletedNCT00075062
• Patient-Provider Trust Among Individuals With End-Stage Kidney DiseaseCompletedNCT00075036
• Obesity and Fatty Acid Flux Comparison TrialsCompletedNCT00074945
• Protective Brace to Prevent Hand and Arm InjuriesCompletedNCT00074893Not applicable
• The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic CardiomyopathyCompletedNCT00074880
• National Registry for Ichthyosis and Related DisordersCompletedNCT00074685
• Relationship Between Sensory and Motor Systems in Restless Leg SyndromeCompletedNCT00074672
• Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment ModelCompletedNCT00074633Not applicable
• Scleroderma RegistryCompletedNCT00074568
• Registry for African Americans With Early Rheumatoid ArthritisCompletedNCT00074555
• Kidney Transplantation in Patients With CystinosisCompletedNCT00074516
• PET Imaging of DHA MetabolismCompletedNCT00074503

← National Institutes of Health overview and focus areas